Before you stop reading because you think this topic is a no-brainer, think again! Combination products are not nearly as simple or straightforward as so many seem to think.
Consider this: combination products make up more than 30% of all new healthcare products currently under development and the global market for combination products is over $115B!
So, what makes combination products so valuable in today’s healthcare market?
During this webinar, we will explore the seemingly simple question at the root of these unique products: what can combination products do that medical devices, drugs and biologics alone cannot?
Participants will learn through real use cases from a wide range of combination products on the market, under development and on the drawing board.
Join regulatory expert Michael Drues, Ph.D., in this free, interactive webinar where you'll discuss real products from a variety of clinical specialities such as drug-eluting stents and balloons, pre-loaded syringes and transdermal patches, drug-biologic combinations and companion diagnostics as well as more complex types, like 3-D printing, personalized medicine, tissue engineering and biomedical nanotechnology.
And this is just the tip of the iceberg! Bottom line: combination products found on the market today, while important, are only rough drafts compared to the masterpieces they can become with the right knowledge base, support, and plan.
Geared for both experienced medical technology professionals as well as those new to the industry, this webinar is designed for those who need a better understanding of the current regulatory requirements and concepts around combination products as well as those in the following roles:
Greenlight Guru is a modern quality management software platform used by medical device companies in over 25 countries to bring new products to market faster while simplifying regulatory compliance and reducing risk. Being the only industry specific, cloud-based eQMS, Greenlight Guru is easier to implement, easier to use and simply fits medical device processes out-of-the-box allowing companies to innovate faster and be more efficient. Visit our homepage to learn more.
Michael Drues, Ph.D., is a regulatory strategy consultant specializing in designing novel regulatory strategies to bring new and innovative medical products to market and in developing effective communication strategies between companies and regulatory agencies to minimize time to market and avoid delays.
His consultancy, Vascular Sciences is a consulting and training company offering a broad range of services to medical device, pharmaceutical & biotechnology companies including creative regulatory strategy & competitive regulatory intelligence, regulatory submission design, FDA presentation preparation & defense. If you'd like to learn more click here.